In a shock to the Aam Aadmi Party, Raghav Chadha, along with 6 other Rajya Sabha MPs, quit the Arvind Kejriwal-led party on Friday, and merged with the BJP. Those who left with Chadha are the group of ...

NEW DELHI: When AAP announced its Rajya Sabha nominees from Punjab in 2022, the spotlight was not on Lovely Professional University founder Ashok Mittal or cricketer Harbhajan Singh, but on the ...

Rajya Sabha MPs Raghav Chadha, Ashok Mittal, and Sandeep Pathak on Friday quit the Aam Aadmi Party (AAP) in a big jolt to Arvind Kejriwal and joined the Bharatiya Janata Party (BJP). Addressing a ...

Corporate watchdog ASIC has revealed it is investigating "individuals" within steel tycoon Sanjeev Gupta's portfolio of industrial companies. Three of those have now collapsed in Australia, leaving ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

The businessman who masterminded a huge nickel fraud against Trafigura Group was named by Mauritius as the ultimate beneficiary of toxic loans that led to the collapse of a local lender. Prateek Gupta ...

When neurosurgeon and journalist Dr. Sanjay Gupta set out to write a book about pain, it wasn't because he felt like he had all the answers. It was because he was still so often mystified by it. "Most ...

Ritika Gupta is CNBC's UK reporter based in London, covering key moments and compelling topics from The City of London and around the United Kingdom. Got a confidential news tip? We want to hear from ...

Why do we have pain in the absence of injury, or long after our tissue has healed? How can the same pain stimulus feel so different, depending on who you are, or even what day it is? Neurosurgeon and ...

LONDON, Feb 26 (Reuters) - Indian businessman Prateek Gupta was refused permission by London's High Court on Thursday to appeal against a ruling that he defrauded commodities trader Trafigura over ...

Standout achievement in 2025: Transformed Lupin's U.S. business into the nation's third-largest generic medicine supplier, launching roughly a dozen new medications and securing reappointment as CEO ...